Observational Study of the Efficiency of Treatments in Patients Hospitalized with Covid-19 in Madrid
Bernaola et al.,
Observational Study of the Efficiency of Treatments in Patients Hospitalized with Covid-19 in Madrid,
medRxiv, doi:10.1101/2020.07.17.20155960 (Preprint)
HCQ HR 0.83 [0.77-0.89] based on propensity score matched retrospective analysis of 1,645 hospitalized patients. Prednisone HR 0.85 [0.82-0.88], 14 other medications showed either no signicant benefit or a negative effect.
risk of death, 17.0% lower, HR 0.83, p < 0.001, treatment 236 of 1,498 (15.8%), control 28 of 147 (19.0%), NNT 30.
|
Effect extraction follows pre-specified rules prioritizing more serious outcomes. Submit updates
|
Bernaola et al., 21 Jul 2020, retrospective, Spain, preprint, 7 authors.
Abstract: medRxiv preprint doi: https://doi.org/10.1101/2020.07.17.20155960; this version posted July 21, 2020. The copyright holder for this preprint
(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.
It is made available under a CC-BY-NC 4.0 International license .
Observational Study of the Efficiency of
Treatments in Patients Hospitalized with
Covid-19 in Madrid
Nikolas Bernaola1, †,*, Raquel Mena2, †, Ander Bernaola3 , Cesar Carballo4 , Antonio Lara5 , Concha
Bielza1 , Pedro Larrañaga1
Universidad Politécnica de Madrid, Spain.2 Universidad Complutense de Madrid, Spain 3 Universidad Francisco de Vitoria, Madrid, Spain
Hospital Universitario Ramon y Cajal, Madrid, Spain 5 Hospital Universitario Sanitas La Zarzuela, Madrid, Spain
*
Corresponding author: nikolasbernaola@gmail.com
1
4
†
These authors contributed equally to this work.
Abstract
Background
Many different treatments were heavily administered to patients with COVID-19 during the
peak of the pandemic in Madrid without robust evidence supporting them.
Methods
We examined the association between sixteen treatments in four groups (steroids, antivirals,
antibiotics and immunomodulators) and intubation or death. Data were obtained from
patients that were admitted to an HM hospital with suspicion of COVID-19 until 24/04/2020,
excluding unconfirmed diagnosis, those who were admitted before the epidemic started in
Madrid, had an outcome that was not discharge or death or died within 24 hours of
presentation. We compared outcomes between treated and untreated patients using
propensity-score caliper matching.
Results
Of 2,307 patients in the dataset, 679 were excluded. Of the remaining 1,645 patients, 263
(16%) died and 311 (18.9%) died or were intubated. Except for hydroxychloroquine and
prednisone, patients that were treated with any of the medications were more likely to go
through an outcome of death or intubation at baseline. After propensity matching we found
an association between treatment with hydroxychloroquine and prednisone and better
outcomes (hazard ratios with 95% CI of 0.83 ± 0.06 and 0.85 ± 0.03). Results were similar in
multiple sensitivity analyses.
Conclusions
In this multicenter study of patients admitted with COVID-19 hydroxychloroquine and
prednisone administration was found to be associated with improved outcomes. Other
treatments were associated with no effect or worse outcomes. Randomized, controlled trials
of these medications in patients with COVID-19 are needed to avoid heavy administration of
treatments with no strong evidence to support them.
NOTE: This preprint reports new research that has not been certified by peer review and should not be used to guide clinical practice.
medRxiv preprint doi: https://doi.org/10.1101/2020.07.17.20155960; this version posted July 21, 2020. The copyright holder for this preprint
(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.
It is made available under a CC-BY-NC 4.0 International license .
Late treatment
is less effective
Please send us corrections, updates, or comments. Vaccines and
treatments are complementary. All practical, effective, and safe means should
be used based on risk/benefit analysis. No treatment, vaccine, or intervention
is 100% available and effective for all current and future variants. We do not
provide medical advice. Before taking any medication, consult a qualified
physician who can provide personalized advice and details of risks and
benefits based on your medical history and situation.
FLCCC and
WCH
provide treatment protocols.
Submit